EBioMedicine (Jan 2022)
Corrigendum to “The CD24+ cell subset promotes invasion and metastasis in human osteosarcoma” [EBioMedicine 51(2020)102598]
- Zhenhua Zhou,
- Yan Li,
- Muyu Kuang,
- Xudong Wang,
- Qi Jia,
- Jiashi Cao,
- Jingjing Hu,
- Sujia Wu,
- Zhiwei Wang,
- Jianru Xiao
Affiliations
- Zhenhua Zhou
- Department of Orthopaedic Oncology, Changzheng Hospital, Naval Medical University (The Second Military Medical University), Shanghai, 200003,China
- Yan Li
- Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032,China
- Muyu Kuang
- Huadong Hospital, Fudan University, Shanghai,200040, China
- Xudong Wang
- Department of Orthopaedic Oncology, Changzheng Hospital, Naval Medical University (The Second Military Medical University), Shanghai, 200003,China
- Qi Jia
- Department of Orthopaedic Oncology, Changzheng Hospital, Naval Medical University (The Second Military Medical University), Shanghai, 200003,China
- Jiashi Cao
- Department of Orthopaedic Oncology, Changzheng Hospital, Naval Medical University (The Second Military Medical University), Shanghai, 200003,China
- Jingjing Hu
- Clinical Research Center, Changhai Hospital, Naval Medical University (The Second Military Medical University), Shanghai 200433, China
- Sujia Wu
- Department of Orthopedics, Nanjing General Hospital of Nanjing Military Region, Nanjing, Jiangsu, 210002, China
- Zhiwei Wang
- Department of Orthopedics, Changhai Hospital, Naval Medical University (The Second Military Medical University), Shanghai, 200433, China; Corresponding authors.
- Jianru Xiao
- Department of Orthopaedic Oncology, Changzheng Hospital, Naval Medical University (The Second Military Medical University), Shanghai, 200003,China; Corresponding authors.
- Journal volume & issue
-
Vol. 75
p. 103775
